Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
CLBT 
Cellebrite DI (CLBT)
Top performer
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/15/2025: CLBT (4-star) is a STRONG-BUY. BUY since 16 days. Simulated Profits (8.19%). Updated daily EoD!
Upturn Star Rating
Above Average Performance
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Number of Analysts
8 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $22.57
1 Year Target Price $22.57
| 6 | Strong Buy |
| 2 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 172.84% | Avg. Invested days 75 | Today’s Advisory Strong Buy |
Upturn Star Rating | Upturn Advisory Performance  5.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 09/15/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.11B USD | Price to earnings Ratio - | 1Y Target Price 22.57 |
Price to earnings Ratio - | 1Y Target Price 22.57 | ||
Volume (30-day avg) 8 | Beta 1.28 | 52 Weeks Range 13.10 - 26.30 | Updated Date 09/15/2025 |
52 Weeks Range 13.10 - 26.30 | Updated Date 09/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.72 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -34.56% | Operating Margin (TTM) 14.58% |
Management Effectiveness
Return on Assets (TTM) 5.95% | Return on Equity (TTM) -81.98% |
Valuation
Trailing PE - | Forward PE 37.17 | Enterprise Value 3657227980 | Price to Sales(TTM) 9.4 |
Enterprise Value 3657227980 | Price to Sales(TTM) 9.4 | ||
Enterprise Value to Revenue 8.37 | Enterprise Value to EBITDA 93.78 | Shares Outstanding 244468992 | Shares Floating 112431342 |
Shares Outstanding 244468992 | Shares Floating 112431342 | ||
Percent Insiders 44.61 | Percent Institutions 49.91 |
Upturn AI SWOT
Cellebrite DI
Company Overview
History and Background
Cellebrite DI was founded in 1999 in Israel as a mobile forensics company, initially focusing on data transfer between mobile phones. Over time, it has evolved into a leading provider of digital intelligence solutions for law enforcement, government agencies, and enterprises. Cellebrite went public through a SPAC merger in 2021.
Core Business Areas
- Digital Intelligence Solutions: Provides solutions for accessing, collecting, analyzing, and managing digital evidence from various sources, including mobile devices, computers, and cloud storage.
- Analytics and Insights: Offers tools for data analytics, visualization, and reporting to help investigators uncover insights and patterns within digital evidence.
- Training and Support: Provides training programs, technical support, and consulting services to help customers effectively utilize Cellebrite's solutions.
Leadership and Structure
Cellebrite is led by a CEO and a senior management team responsible for overseeing various departments, including sales, marketing, product development, and operations. The company has a global presence with offices and partners worldwide.
Top Products and Market Share
Key Offerings
- UFED (Universal Forensic Extraction Device): A hardware and software solution for extracting and decoding data from mobile devices. Market share is estimated around 45% in the mobile forensic extraction market. Major competitors include Magnet Forensics and MSAB. Revenue from UFED is significant, contributing to a large portion of Cellebrite's revenue.
- Cellebrite Premium: A service providing access to locked or encrypted iOS and Android devices. Revenue data is not publicly available, but it's a key growth area. Competitors include GrayKey (Grayshift).
- Cellebrite Pathfinder: An AI-powered analytics platform for analyzing and visualizing digital evidence. Competitors include Nuix. Revenue data specifically for Pathfinder is not publicly available, but it's a strategic part of their analytics offerings.
Market Dynamics
Industry Overview
The digital intelligence market is growing rapidly due to the increasing volume and complexity of digital evidence in criminal investigations and legal proceedings. Demand is driven by law enforcement agencies, government organizations, and enterprises needing to efficiently collect, analyze, and manage digital data.
Positioning
Cellebrite DI is positioned as a market leader in digital intelligence solutions, with a strong brand reputation, a comprehensive product portfolio, and a large customer base. Its competitive advantages include its advanced technology, extensive device support, and global reach.
Total Addressable Market (TAM)
The total addressable market (TAM) for digital intelligence is estimated to be in the billions of dollars. Cellebrite DI is well-positioned to capture a significant share of this market, focusing on innovation, customer relationships, and strategic partnerships.
Upturn SWOT Analysis
Strengths
- Strong brand recognition
- Comprehensive product portfolio
- Large customer base
- Advanced technology
- Global reach
Weaknesses
- Reliance on government contracts
- Ethical concerns regarding privacy
- High price point of products
- Potential for negative publicity
Opportunities
- Expanding into new markets (e.g., cybersecurity)
- Developing new products and services (e.g., cloud-based solutions)
- Acquiring complementary businesses
- Increasing demand for digital intelligence solutions
Threats
- Increasing competition
- Changes in regulations and laws
- Technological advancements making products obsolete
- Data security breaches
Competitors and Market Share
Key Competitors
- MSAB.ST
- GRYP
Competitive Landscape
Cellebrite has advantages in extraction technology and comprehensive solutions. Competitors such as MSAB have strong market presence and specialized offerings. Grayshift competes strongly in locked device access.
Major Acquisitions
Comintoo
- Year: 2020
- Acquisition Price (USD millions): 18.5
- Strategic Rationale: To expand Cellebrite's digital intelligence platform with advanced data analytics and AI capabilities.
Growth Trajectory and Initiatives
Historical Growth: Cellebrite DI has experienced strong revenue growth in recent years, driven by increasing demand for digital intelligence solutions.
Future Projections: Analysts project continued revenue growth for Cellebrite DI, driven by expanding markets and new product offerings.
Recent Initiatives: Recent strategic initiatives include expanding into new geographic regions, developing cloud-based solutions, and acquiring complementary businesses.
Summary
Cellebrite is a leading digital intelligence provider with a strong brand and technology. Revenue growth is consistent, but profitability is a concern. Key strengths are its UFED product and established customer base. Privacy concerns and competition pose ongoing risks and opportunities to overcome.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Cellebrite DI Investor Relations
- SEC Filings
- Industry Reports
- Analyst Reports
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Market data and analyst estimates are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cellebrite DI
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2021-08-31 | CEO & Director Mr. Thomas E. Hogan | ||
Sector Technology | Industry Software - Infrastructure | Full time employees 1167 | Website https://www.cellebrite.com |
Full time employees 1167 | Website https://www.cellebrite.com | ||
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to access, collect, review, extract, decode, decrypt, analyze, share, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Endpoint Mobile Now; and professional services, such as training and certification services, and advanced services. It serves federal and state and local agencies. The company was founded in 1999 and is headquartered in Petah Tikva, Israel.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.